How does this financing round compare to prior capital raises in terms of valuation and dilution?

Short answer:

Based on the press release you provided, the only quantitative details we have about the current financing are:

The release does not disclose any of the following information that would be required to make a meaningful comparison with Wearable Devices Ltd.’s earlier capital‑raising rounds:

• The total number of shares outstanding (or fully‑diluted shares) before the warrant exercise.
  
• The price per share (or implied valuation) at which prior rounds were raised.
  
• The type of securities previously issued (e.g., common stock, preferred stock, convertible notes, other warrants).
  
• Any anti‑dilution protections or price‑adjustment mechanisms that were part of earlier transactions.
  
• The amount of capital raised in those prior rounds.

Because those data points are missing, we cannot quantitatively determine:

1. Valuation comparison – Whether the $1.45 per‑share price reflects a higher, lower, or comparable valuation to the prices paid in earlier rounds.
   
2. Dilution impact – What percentage of the company’s equity the 1,661,000 newly‑issued shares represent relative to the pre‑transaction share count, and how that compares to the dilution incurred in previous financings.

How you could assess valuation and dilution if the missing data were available

Below is the framework you (or an analyst) would use once the necessary numbers are known.

Illustrative example (hypothetical numbers):

Note: The numbers above are purely illustrative and do not reflect Wearable Devices Ltd.’s actual capital structure.

What you can do next

1. Locate prior financing disclosures – Look for the company’s SEC filings (e.g., Form 8‑K, S‑1, 10‑Q/10‑K) or press releases that announced earlier rounds. Those documents usually state:

   • Number of shares issued,
   • Price per share,
   • Total proceeds,
   • Post‑money valuation (sometimes).

2. Obtain the current share count – The latest 10‑Q or 10‑K will list the “issued and outstanding shares” (both basic and fully diluted). This figure is needed to calculate dilution.

3. Re‑run the calculations – Plug the real numbers into the tables above to see:

   • How the $1.45 warrant price compares to previous round prices,
   • Whether the company’s implied valuation has risen or fallen,
   • The exact dilution percentage attributable to this warrant exercise and its cumulative effect.

Bottom line

• With the information given (only the warrant size, price, and gross proceeds), we cannot definitively compare this financing round to Wearable Devices Ltd.’s prior capital raises in terms of valuation or dilution.
  
• Once you obtain the company’s total share count and the pricing/size of earlier rounds, the simple formulas and comparative approach outlined above will let you answer the question quantitatively.